RND1

Across TCGA pan-cancer cohorts, RND1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RND1 data layer compared with 28 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher RND1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RND1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and BLCA show a favorable association.

KICH, BRCA, and UCEC are the cancer types where RND1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
BRCA	DFS	Median	All	0.679	0.902	.025	8	view →
UCEC	DFS	Median	II,III,IV	1.000	0.443	.034	4	view →
BLCA	DFS	Median	III,IV	0.511	0.315	.047	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RND1–KICH (DFS)

Open the KICH breakdown →